Last week it was 28. This week, it’s more than 70. That’s how many pets have died after eating Sportmix pet food due to suspected aflatoxin poisoning.
Last month, Sunshine Mills issued a dog food recall due to high levels of aflatoxin. Yesterday, they expanded the recall. Today, the FDA stepped in.
This week: Some medical students get out of school early to join the fray, human medical workers told to keep mum on COVID-19, and good news on the testing-pets-for-coronavirus front.
Say the US Food and Drug administration has issued another pet food recall. Some animals are dying. Are your patients at risk? Imagine being able to comb through all your patient records with a couple of keystrokes and identify how many patients in the last month came in presenting with the same set of gastrointestinal symptoms. Scientists at Stanford University teamed up with veterinarians at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences to develop
This week: Former musher hopes sled dogs can help slow aging in humans, a canine lieutenant commander in the Navy, and the Dallas Cowboys add a cat to the roster.
An easily scannable fact sheet to use in your practice.
If you’re running thin on surgical masks and other personal protective equipment (PPE) due to coronavirus-related shortages, you’re not alone. The FDA doesn’t have any extra masks to loan you, but they do have tips to help you cope.
The CDC and the USDA announced last week the first confirmed cases of SARS-CoV-2 infection in two pet cats in New York State. In the wake of that announcement, the CDC now recommends that pet owners follow the same social distancing guidelines with their pets as with human family members.
The warning letter is only the latest step in a story that’s been unfolding since late last year when the company issued a voluntary pet food recall due to reports of possible aflatoxin contamination.
What does the human health crisis around xylazine mean for the future availability of this drug for veterinary use? Emily Singler, VMD, offers a snapshot of where we are currently in the race to regulate xylazine—and the potential impacts on vet med.